References
- Rees RC. Cytokines as biologic response modifiers. J Clin Path 1992;45:93-8.
- Davenport RD, Strieter RM, Standiford TJ, Kunkel SL. Interleukin-8 production in red blood cell incompatability. Blood 1990;76:2439-42.
- Davenport RD, Strieter RM, Kunkel SL. Red cell ABO incompatibility and production of tumour necrosis factor-alpha. Br J Haematol 1991;78:540-4.
- Davenport RD, Burdick M, Strieter RM, Kunkel SL. Monocyte chemoattractant protein production in red cell incompatibility. Transfusion 1994;34:16-9.
- Davenport RD, Polak TJ, Kunkel SL. White cell-associated procoagulant activity induced by ABO incompatibility. Transfusion 1994;34:943-9.
- Butler J, Parker D, Pillai R, Shale DJ, Rocker GM. Systemic release of neutrophil elastase and tumor necrosis factor alpha following ABO incompatible blood transfusion. Br J Haematol 1991;79:525-6.
- Capon SM, Goldfinger D. Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 1995; 35:513-20.
- Davenport RD, Burdick M, Moore SA, Kunkel SL. Cytokine production in IgG-mediated red cell incompatibility. Transfusion 1993;33:19-24.
- Hoffman M. Antibody-coated erythrocytes induce secretion of tumor necrosis factor by human monocytes: a mechanism for the production of fever by incompatible transfusions. Vox Sang 1991;60:184-7.
- Davenport RD, Burdick MD, Strieter RM, Kunkel SL. In vitro production of interleukin-1 receptor antagonist in IgG-mediated red cell incompatability. Transfusion 1994;34:297-303.
- Goldfinger D. Acute hemolytic transfusion reactions—a fresh look at pathogenesis and considerations regarding therapy. Transfusion 1977;17:85-98.
- Sazama K. Reports of 355 transfusion-associated deaths: 1976-1985. Transfusion 1990;30:583-90.
- Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990;30:688–93.
- Mangano MM, Chambers LA, Kruskall MS. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. Am J Clin Pathol 1991;95:733–8.
- Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion 1993;33:794–7.
- Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625–8.
- Muylle L, Joos M, Wouters E, DeBock R, Peetermans ME. Increased tumor necrosis factor a (TNFa), interleukin 1 and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFa and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195–9.
- Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994;34:20–5.
- Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35: 117–24.
- Stack G, Baril L, Napychank P, Snyder EL. Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 1995;35:199–203.
- Federowicz I, Barrett BB, Andersen JW, Urashima M, Popovsky MA, Anderson KC. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion 1996;36:21–8.
- Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Scientific Publications, 1993:690–6.
- Frewin DB, Jonsson JR, Head RJ, Russell WJ, Beal RW. Histamine levels in stored human blood. Transfusion 1984; 24:502–4.
- Muylle L, Laekeman G, Herman AG, Peetermans ME. Histamine levels in stored platelet concentrates. Relationship to white cell content. Transfusion 1988;28:226–8.
- Frewin DB, Jonsson JR, Davis KG, et al. Effect of microfiltration on the histamine levels in stored human blood. Vox Sang 1987;52:191–4.
- Stack G, Snyder EL. Leukodepletion to prevent transfusion reactions: effects on cytokines and other biologic response modifiers. In: Sweeney J, Heaton A, eds. Clinical benefits of leukodepleted blood products. RG Landes Company, 1995.
- Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990;76:1438–44.
- Popovsky MA, Moore SB. Diagnostic and pathogenic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573–7.
- Popovsky MA, Abel MD, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983;128:185–9.
- Van Buren NL, Stroncek DF, Clay ME, McCullough J, Dalmasso AP. Transfusion-related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura. Transfusion 1990;30:42–5.
- Yomtovian R, Kline W, Press C, et al. Severe pulmonary hypersensitivity associated with passive transfusion of a neutrophilspecific antibody. Lancet 1984;1:244–6.
- Nordhagen R, Conradi M, Dromtorp S. Pulmonary reaction associated with transfusion of plasma containing anti-5b. Vox Sang 1986;51:102–7.
- Koll BS, Brown AE. Infections associated with blood-product transfusions in patients with cancer. Infect Med 1993;10: 12,17–8.
- Tipple MA, Bland LA, Murphy JJ, et al. Sepsis associated with transfusion of red cells contaminated with Yersinia entero-colitica. Transfusion 1990;30:207–13.
- Franzin L, Gioannini P. Growth of Yersinia species in artificially contaminated blood bags. Transfusion 1992;32:673–6.
- Heltberg O, Skov F, Gerner-Smidt P, et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion 1993;33:221–7.
- Morrow JF, Braine HG, Kickler TS, Ness PM, Dick JD, Fuller AK. Septic reactions to platelet transfusions. JAMA 1991;266:555–8.
- Hogman CF, Gong J, Hambraeus A, Johansson CS, Eriksson L. The role of white cells in the transmission of Yersinia enterocolitica in blood components. Transfusion 1992;32:654–7.
- Kim DM, Brecher ME, Bland LA, et al. Prestorage removal of Yersinia enterocolitica from red cells with white cell reduction filters. Transfusion 1992;32:658–62.
- Wenz B, Burns ER, Freundlich LF. Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtration. Transfusion 1992;32:663–6.
- Buchholz DH, AuBuchon JP, Snyder EL, et al. Removal of Yersinia enterocolitica from AS-1 cells. Transfusion 1992; 32:667–72.
- Wenz B, Ciavarella D, Freundlich L. Effect of prestorage white cell reduction on bacterial growth in platelet concentrates. Transfusion 1992;33:520–3.
- Anderson KC, Weinstein HJ. Transfusion-associated graft-ver-sus-host disease. N Engl J Med 1990;323:315–21.
- Sakakibara T, Juji T. Post-transfusion graft-versus-host disease after open heart surgery. Lancet 1986;2:1099.
- Ohoto H, Yasuda H, Noguchi M, Abe R. Risk of transfusion-associated graft-versus-host disease as a result of directed donations from relatives (letter). Transfusion 1992;32:691–3.
- Standards for blood banks and transfusion services. 17th ed. Bethesda, MD: American Association of Blood Banks, 1995.
- Leitman SF, Holland PV. Irradiation of blood products. Indications and guidelines. Transfusion 1985;25:293–300.
- Dzik WH, Jones KS. The effects of gamma irradiation versus white cell reduction on the mixed lymphocyte reaction. Transfusion 1993;33:493–6.
- Popovsky MA, Taswell HF. Circulatory overload: an underdiagnosed consequence of transfusion (abstract). Transfusion 1985;25:469.